Uveítis inducida por fármacos

  1. J Cano Parra
  2. M Díaz-Llopis
Revista:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Año de publicación: 2005

Volumen: 80

Número: 3

Páginas: 137-149

Tipo: Artículo

DOI: 10.4321/S0365-66912005000300004 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Archivos de la Sociedad Española de Oftalmologia

Objetivos de desarrollo sostenible

Resumen

Objetivo: Revisión de la literatura de los casos de uveítis inducida por fármacos. Métodos: Aplicación de los criterios de la OMS y de Naranjo para clasificar según lo publicado en la literatura los casos de uveítis inducida por fármacos en reacciones de causalidad cierta, probable y posible. Descripción de los cuadros clínicos de uveítis asociados a cada fármaco. Resultados: Uveítis de causalidad cierta son la causadas: por bifosfonatos, topiramato y metipranolol tópico. Uveítis de causalidad probable: Rifabutina, sulfonamidas, cidofovir, inmunorrecuperación por terapia HAART, corticoides tópicos, latanoprost y acetato de triamcinolona intravítreo. Uveítis de causalidad sólo posible por: bimatoprost, travopost, brimonidina, otras medicaciones tópicas y fármacos intraoculares, síndrome TINU asociado a AINES, contraste yodado no iónico (iopamidol), dietilcarbamazepina, interleukina 3 y 6, contraceptivos orales, quinidina vacunas y cobalto, ibuprofeno y moxifloxacino. Conclusiones: La uveítis inducida por fármacos es una entidad de baja frecuencia, que produce uveítis principalmente anterior solamente, con afectación moderada de agudeza visual y que cuando se suspende el fármaco no tiene recurrencias.

Referencias bibliográficas

  • Fraunfelder, FW, Rosembaum, JT. (1997). Drug-induced uveitis: Incidence, prevention and treatment. Drug Saf. 17. 197-207
  • Calonge, M.. (2002). Diagnosis and treatment of uveitis. W. B. Saunders Company. Philadelphia.
  • Fraunfelder, FW, Fraunfelder, FT. (2004). Adverse ocular reactions recently identified by the National Registry of Drug-induced Ocular Side Effects. Ophthalmology. 111. 1275-1279
  • Naranjo, CA, Busto, U, Sellers, EM, Sandor, P, Ruiz, I, Roberts, EA. (1981). A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 30. 239-245
  • Moorthy, RS, Valluri, S, Jampol, LM. (1998). Drug-induced uveitis. Surv Ophthalmol. 42. 557-570
  • Macarol, V, Fraunfelder, FT. (1994). Pamidronate disodium and possible ocular adverse drug reactions. Am J Ophthalmol. 118. 220-224
  • Akingbehin, T, Villada, JR. (1991). Metipranolol-associated granulomatous uveitis. Br J Ophthalmol. 75. 519-523
  • Melles, RB, Wong, IG. (1994). Metipranolol-associated granulomatous iritis. Am J Ophthalmol. 118. 712-715
  • Van Buskirk, EM. (1980). Adverse reactions from timolol administration. Ophthalmology. 87. 447-450
  • Jain, S. (1994). Betaxolol-associated anterior uveitis. Eye. 8. 708-709
  • Siegal, FP, Eilbott, D, Burger, H, Gehan, K, Davidson, B, Kaell, AT. (1990). Dose-limiting toxicity of rifabutin in AIDS- related complex: syndrome of arthralgia/arthritis. AIDS. 4. 433-441
  • Shafran, SD, Deschenes, J, Miller, M, Phillips, P, Tana, E.. (1994). Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin and ethambutol: MAC Study Group of the Canadian HIV Trials Network. N Eng J Med. 330. 438-439
  • Arevalo, JF, Russack, V, Freeman, WR. (1997). New ophthalmic manifestations of presumed rifabutin-related uveitis. Ophthalmic Surg Lasers. 28. 321-324
  • Tilden, ME, Rosenbaum, JT, Fraunfelder, FT. (1991). Systemic sulfonamides as a cause of bilateral, anterior uveitis. Arch Ophthalmol. 109. 67-69
  • Kristinsson, JK, Hannesson, OB, Sveinsson, O, Thorleifsson, H. (1997). Bilateral anterior uveitis and retinal haemorrhages after administration of trimetroprim. Acta Ophthalmol Scand. 75. 314-315
  • Taskintuna, I, Rahhal, FM, Arevalo, JF, Munguia, D, Banker, AS, De Clercq, E. (1997). Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 104. 1049-1057
  • Taskintuna, I, Rahhal, FM, Rao, NA, Wiley, CA, Mueller, AJ, Banker, AS. (1997). Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome. Ophthalmology. 104. 1827-1836
  • Song, MK, Azen, SP, Buley, A, Torriani, F, Cheng, L, Chaidhawangul, S. (2003). Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol. 136. 696-702
  • Martins, JC, Wilensky, JT, Asseff, CF, Obstbaum, SA, Buerk, Km. (1974). Corticosteroid-induced uveitis. Am J Ophthalmol. 77. 433-437
  • Camras, CB, Alm, A, Watson, P, Stjernschantz, J.. (1996). Latanoprost, a prostaglandin analog, for glaucoma therapy: Efficacy and safety after 1 year of treatment of 198 patients. Latanoprost Study Groups. Ophthalmology. 103. 1916-1924
  • Fechtner, RD, Khouri, AS, Zimmerman, TJ, Bullock, J, Feldman, R, Kulkarni, P. (1998). Anterior uveitis associated with latanoprost. Am J Ophthalmol. 126. 37-41
  • Warwar, RE, Bullock, JD, Ballal, D. (1998). Cystoid macular edema and anterior uveitis associated with latanoprost use: Experience and incidence in a retrospective review of 94 patients. Ophthalmology. 105. 263-268
  • Smith, SL, Pruitt, CA, Sine, CS, Hudgins, AC, Stewart, WC. (1999). Latanoprost 0. 005% and anterior segment uveitis. Acta Ophthalmol Scand. 77. 668-672
  • Moshfeghi, AA, Scott, IU, Flynn, HW, Puliafito, CA. (2004). Pseudohypopion alter intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol. 138. 489-492
  • Roth, DB, Chieh, J, Spirn, MJ, Green, SN, Yarian, DL, Chaudhry, NA. (2003). Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol. 121. 1279-1282
  • Hernaez-Ortega, MC, Soto-Pedre, E. (2004). A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection. Ophthalmic Surg Lasers Imaging. 35. 350-351
  • Bakri, SJ, Shah, A, Falk, NS, Beer, PM.. (2004). Intravitreal preservative-free trimcinolone acetonide for the treatment of macular edema. Eye. 27.
  • Packer, M, Fine, IH, Hoffman, RS. (2003). Bilateral nongranulomatous anterior uveitis associated with bimatoprost. J Cat Refract Surg. 29. 2242-2243
  • Parentin, F. (2003). Granulomatous anterior uveitis associated with bimatoprost: a case report. Ocul Immunol Inflamm. 11. 67-71
  • Faulkner, WJ, Burk, SE. (2003). Acute anterior uveitis and corneal edema associated with travoprost. Arch Ophthalmol. 121. 1054-1055
  • Kumarasamy, M, Desai, SP. (2004). Anterior uveitis is associated with travoprost. BMJ. 329. 205
  • Byles, DB, Frith, P, Salmon, JF. (2000). Anterior uveitis as a side effect of topical brimonidine. Am J Ophthalmol. 130. 287-291
  • Fraunfelder, FT, Grove, JA.. (1996). Drug-induced ocular side effects and drug interactions. Lea and Febiger. Philadelphia.
  • Chapman-Smith, JS, Crock, GW. (1977). Urokinase in the management of vitreous hemorrhage. Br J Ophthalmol. 61. 500-505
  • Rosembaum, JT. (1988). Bilateral anterior uveitis and interstitial nephritis. Am J Ophthalmol. 105. 534-537
  • Welzl-Hinlerkorner, E, Haefner, M, Mengiardi, B. (2003). Unilateral uveitis by a nonionic iodinated contrast agent. Am J Ophthalmol. 136. 958-960
  • Taylor, HR, Greene, BM. (1981). Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis. Br J Ophthalmol. 65. 494-502
  • Wu, WC, Mannion, B, Stone, RM. (1995). Uveitis associated with interleukin-3 and -6 therapy. Arch Ophthalmol. 113. 408-409
  • Davidson, SI. (1971). Reported adverse effects of oral contraceptives on the eye. Trans Ophthalmol Soc UK. 91. 561-574
  • Hustead, JD. (1991). Granulomatous uveitis and quinidine hypersensitivity. Am J Ophthalmol. 112. 461-462
  • Kaplan, BH, Nevitt, MP, Pach, JM, Herman, DC. (1994). Aseptic meningitis and iridocyclitis related to ibuprofen. Am J Ophthalmol. 117. 119-120
  • Bringas Calvo, R, Iglesias Cortinas, D. (2004). Uveítis anterior aguda bilateral secundaria a moxifloxacino. Arch Soc Esp Oftalmol. 79. 357-359
  • Donaldson, RC, Canaan, SA, McLean, RB, Ackerman, LV. (1974). Uveitis and vitiligo associated with BCG treatment for malignant melanoma. Surgery. 76. 771-778
  • Lish, A, Berman, DH. (1993). Tuberculin-triggered panuveitis in a patient recently treated for active pulmonary tuberculosis. Am J Ophthalmol. 116. 771-773
  • Nussenblatt, RB, Whitcup, SM, Palestine, AG.. (1995). Uveitis: Fundamentals and clinical practice. Mosby Year Book. St. Louis.
  • Blumberg, S, Bienfang, D, Kantrowitz, FG. (1980). A possible association between influenza vaccination and small-vessel vasculitis. Arch Intern Med. 140. 847-848
  • Knopf, HL. (1991). Recurrent uveitis after influenza vaccination. Ann Ophthalmol. 23. 213-214
  • Rorsman, H, Brehmer-Andersson, E, Dahlquist, I, Ehinger, B, Jacobson, S, Linell, F. (1969). Tattoo granuloma and uveitis. Lancet. 2. 27-28
Fuente de los datos: Dialnet